Comorbid conditions associated with Parkinson's disease: A population‐based study
暂无分享,去创建一个
D. Maraganore | W. Rocca | C. Leibson | J. Bower | J. Ransom | Cynthia L. Leibson | Demetrius M. Maraganore | James H. Bower | Jeanine E. Ransom | Peter C. O'Brien | Walter A. Rocca | P. C. O'Brien
[1] C. Roehrborn,et al. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. , 2000, Urology.
[2] Daniel J Schaid,et al. Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.
[3] C. Naylor,et al. Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort , 2004, Movement disorders : official journal of the Movement Disorder Society.
[4] M. Levine,et al. Genetic Basis for Resistance to Parathyroid Hormone , 2003, Hormone Research in Paediatrics.
[5] B. Ratcliff,et al. Handbook of Parkinson's Disease , 1988, The Yale Journal of Biology and Medicine.
[6] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[7] Daniel J Schaid,et al. Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.
[8] R. Sakakibara,et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease , 2001, Autonomic Neuroscience.
[9] R. Mayeux,et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.
[10] M. Beyer,et al. Causes of death in a community‐based study of Parkinson's disease , 2001, Acta neurologica Scandinavica.
[11] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[12] D. Aarsland,et al. Risk of dementia in Parkinson’s disease: A community-based, prospective study , 2001 .
[13] P. Hobson,et al. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. , 2003, Parkinsonism & related disorders.
[14] G. Schumock,et al. Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] H. Katzen,et al. Cognitive Decline Affects Subject Attrition in Longitudinal Research , 2000, Journal of clinical and experimental neuropsychology.
[16] D. Deleu. Smoking, alcohol, and coffee consumption preceding Parkinson’s disease , 2001, Neurology.
[17] M. Emre. Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.
[18] Demetrius M Maraganore,et al. Medical services utilization and prognosis in Parkinson disease: a population-based study. , 2002, Mayo Clinic proceedings.
[19] D. Maraganore,et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.
[20] J. Olsson,et al. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐up , 2003, Movement disorders : official journal of the Movement Disorder Society.
[21] G. Meco,et al. Mortality in a population‐based cohort of patients treated with antiparkinsonian drugs , 1998, Acta neurologica Scandinavica.
[22] L. Melton,et al. History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.
[23] L. Melton,et al. The threat to medical-records research. , 1997, The New England journal of medicine.
[24] C. C. Johnson,et al. Parkinson's disease and its comorbid disorders , 1994, Neurology.
[25] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[26] J. Cummings,et al. The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.
[27] K. Marder,et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.
[28] M. Hely,et al. The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years , 1999, Journal of neurology, neurosurgery, and psychiatry.
[29] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[30] J. Cummings,et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.
[31] M. Marmot,et al. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.
[32] D. Maraganore,et al. Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study , 2002, Epidemiology.